Pipeline

Pipeline

GBT is advancing a strategic drug discovery, development and commercialization approach that leverages the team’s expertise in blood biology and structural and medicinal chemistry.

Voxelotor (GBT440) Program Overview

Sickle cell disease

HOPE Study
(all genotypes; chronic treatment of adults and adolescents)
    
HOPE-KIDS 1 Study
(safety, exploratory efficacy and PK in 6-17 year olds)